Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA.
| Revenue (Most Recent Fiscal Year) | $0.05M |
| Net Income (Most Recent Fiscal Year) | $-6.99M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 70.77 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.24 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -12227.10% |
| Net Margin (Trailing 12 Months) | -12227.10% |
| Return on Equity (Trailing 12 Months) | -126.89% |
| Return on Assets (Trailing 12 Months) | -106.61% |
| Current Ratio (Most Recent Fiscal Quarter) | 21.68 |
| Quick Ratio (Most Recent Fiscal Quarter) | 21.68 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $27.10 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-9.32 |
| Earnings per Share (Most Recent Fiscal Year) | $-7480.00 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 0.58M |
| Free Float | 0.58M |
| Market Capitalization | $3.84M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 1.13 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.77% |
| Percentage Held By Institutions (Latest 13F Reports) | 7.52% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |